Comparison of Videoconference and Face-to-Face Delivery of Cognitive Processing Therapy for Posttraumatic Stress Disorder

NCT00941629 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2015-10-02

No results posted yet for this study

Summary

The purpose of this study is to evaluate the equivalence of CPT treatment delivered remotely via telemental health (TMH) over videoconferencing or via traditional face-to face (FTF) treatment to veterans who have Post-traumatic Stress Disorder (PTSD) from a military-related stressor (i.e., combat, sexual assault, non-combat physical assault). The secondary objective is to determine if patients' ratings of PTSD symptoms, affect, social adjustment, therapy alliance, treatment satisfaction and therapist satisfaction, are equivalent between service-delivery conditions (TMH vs. FTF). A final objective is to develop web-based practice assignments to assist participants in the TMH condition with treatment adherence (completion of the between- session practice assignments).

Conditions

  • Post-Traumatic Stress Disorder

Interventions

BEHAVIORAL

Cognitive Processing Therapy (CPT)

Patients with PTSD receive a trauma-focused, cognitive-behavioral intervention in Face-to -Face treatment.

BEHAVIORAL

Cognitive Processing Therapy (CPT)

Provision of Cognitive Processing Therapy over teleconference network (telemental health; telehealth)

Sponsors & Collaborators

Principal Investigators

  • Tracey L Smith, Ph.D. · Wm.S. Middleton Memorial Veterans Hospital FWA 00005784

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00941629 on ClinicalTrials.gov